Dai-ichi Life Holdings’s Kite Pharma, Inc. KITE Stock Holding History

Dai-ichi Life Holdings’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-21,016	Closed	-$1.17M	–	537
2016 Q3	$1.17M	Sell	21,016 -1,042	-5%	-$58.1K	0.04%	390
2016 Q2	$1.1M	Buy	22,058 +300	+1%	+$14.7K	0.03%	390
2016 Q1	$999K	Buy	+21,758	New	+$1.05M	0.03%	394

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Dai-ichi Life Holdings's KITE Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Kite Pharma, Inc. (KITE) in Q4 2016, closing a stake of 21,016 shares — an estimated $1.17M sold.

Dai-ichi Life Holdings first reported a position in KITE in Q1 2016 and held it in 3 quarters. The position peaked at $1.17M in Q3 2016. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

Dai-ichi Life Holdings reported no remaining Kite Pharma, Inc. position as of Q4 2016 after selling out during the quarter.
Dai-ichi Life Holdings sold 21,016 Kite Pharma, Inc. shares in Q4 2016, an estimated $1.17M.
Dai-ichi Life Holdings first reported a position in Kite Pharma, Inc. in Q1 2016 and held it in 3 quarters.
Dai-ichi Life Holdings's Kite Pharma, Inc. position peaked at $1.17M in Q3 2016.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.